These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9921916

  • 1. Intracellular markers in acute myeloid leukemia diagnosis.
    Koníková E, Glasová M, Kusenda J, Babusíková O.
    Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F, Latorraca A, Moretti S, Castagnari B, Ferrari L, Castoldi G.
    Cytometry; 1997 Jun 15; 30(3):134-44. PubMed ID: 9222099
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 15; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 6. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
    Leong CF, Kalaichelvi AV, Cheong SK, Hamidah NH, Rahman J, Sivagengei K.
    Malays J Pathol; 2004 Dec 15; 26(2):111-6. PubMed ID: 16329563
    [Abstract] [Full Text] [Related]

  • 7. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG, Metze K, Costa FP, Lima CS, Lorand-Metze I.
    Neoplasma; 2006 Dec 15; 53(2):155-60. PubMed ID: 16575472
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M, Silverman LR, Jiang JD, Yagi MJ, Holland JF, Bekesi JG.
    J Clin Lab Immunol; 1996 Dec 15; 48(4):149-66. PubMed ID: 9819667
    [Abstract] [Full Text] [Related]

  • 12. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N, Kuramoto A, Kawaguchi Y, Tanaka R.
    Rinsho Ketsueki; 1989 Jan 15; 30(1):11-21. PubMed ID: 2541276
    [Abstract] [Full Text] [Related]

  • 13. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
    Kotylo PK, Seo IS, Smith FO, Heerema NA, Fineberg NS, Miller K, Greene ME, Chou P, Orazi A.
    Am J Clin Pathol; 2000 Feb 15; 113(2):193-200. PubMed ID: 10664621
    [Abstract] [Full Text] [Related]

  • 14. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
    Drach J, Drach D, Glassl H, Gattringer C, Huber H.
    Cytometry; 1992 Feb 15; 13(8):893-901. PubMed ID: 1459006
    [Abstract] [Full Text] [Related]

  • 15. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T, Babusíková O.
    Neoplasma; 2006 Feb 15; 53(6):500-6. PubMed ID: 17167719
    [Abstract] [Full Text] [Related]

  • 16. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A, Adib M, Mokarian F, Tebianian M, Nassiri R.
    Med Sci Monit; 2003 Aug 15; 9(8):CR359-62. PubMed ID: 12942032
    [Abstract] [Full Text] [Related]

  • 17. Triple immunofluorescence evaluation of CD15, CD34 and class II expression by flow cytometry in normal and leukemic bone marrows.
    Venditti A, Del Poeta G, Stasi R, De Fabriitis P, Coppetelli U, Bruno A, Simone MD, Papa G.
    Haematologica; 1993 Aug 15; 78(6):359-63. PubMed ID: 7513673
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ, Jacobs BC, Kappers-Klunne MC, Hählen K, Hooijkaas H, van Dongen JJ.
    Leukemia; 1993 Mar 15; 7(3):472-81. PubMed ID: 7680403
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.
    Manaloor EJ, Neiman RS, Heilman DK, Albitar M, Casey T, Vattuone T, Kotylo P, Orazi A.
    Am J Clin Pathol; 2000 Jun 15; 113(6):814-22. PubMed ID: 10874882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.